News & Events about Karuna Therapeutics Inc.
Business Wire
7 months ago
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company) today announces its results for the year ended December 31, 2022, as well as its cash balance as of the first quarter ended March 31, 2023. The following information represents select highlights from the full UK annual report...
Business Wire
8 months ago
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced the pricing of an underwritten public offering of 2,479,391 shares of its common...
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) insider Stephen K. Brannan sold 5,000 shares of the companys stock in a transaction that occurred on Thursday, February 9th. The shares were sold at an average price of $192.37, for a total transaction of $961,850.00. Following the transaction, the ...
Ticker Report
10 months ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) Director James Healy sold 6,027 shares of Karuna Therapeutics stock in a transaction that occurred on Friday, January 13th. The shares were sold at an average price of $199.90, for a total value of $1,204,797.30. Following the completion of ...
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) insider Stephen K. Brannan sold 5,000 shares of the stock in a transaction on Monday, January 9th. The stock was sold at an average price of $197.52, for a total transaction of $987,600.00. Following the completion of the sale, the insider now owns ...